Myeloma cells, depending on auto- and paracrine growth and survival factors like insulin-like growth factor 1 [28, 53–55], profit from their release from the bone marrow environment and degraded bone matrix, constituting a vicious cycle. Here, IGF1 is linked to plasma cell myeloma.